Keywords: genvec, starts, ph, iib, trial, biobypass, usa

GenVec starts Ph IIb trial of Biobypass

Article | 14 March 2005

Print This

GenVec of the USA says it has commenced Phase IIb evaluation of its Biobypass angiogen in patients with severe coronary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in